parthenolide

matrix metallopeptidase 9 ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33367934 Parthenolide inhibits the tumor characteristics of renal cell carcinoma. 2021 Jan 1
2 23086737 Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. 2013 Apr 4
3 23898080 Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells. 2013 Aug 2
4 22884152 Culture supernatants of breast cancer cell line MDA-MB-231 treated with parthenolide inhibit the proliferation, migration, and lumen formation capacity of human umbilical vein endothelial cells. 2012 Jun 1
5 20678173 Role of the NF-κB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes. 2010 Dec 1
6 19269818 Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives. 2009 Apr 1 1
7 17290398 Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. 2007 Jun 15 1